Treatment standards for infectious diseases are changing rapidly – the Elite Research Network can help your study keep up.

Thanks to newly-approved drugs for hepatitis C, HIV and other infections, the standards of care in infectious disease are changing rapidly. The physicians in the Elite Research Network understand how these changes might impact your trial. With access to investigators board certified in infectious disease and general practitioners, our network of sites has the expertise and access to patients for your next infectious disease study, including vaccine studies.

Collectively, we have conducted hundreds of infectious disease and vaccine studies from Phase I through Phase IV. Each of our sites utilizes a central IRB to accelerate study start up. Through a combination of our patient databases and selective advertising, our sites typically meet or exceed enrollment goals in the infectious disease studies we conduct, while providing high quality data to our clients.

Due to our therapeutic expertise in infectious disease, we work with our clients in the feasibility and planning stages of their studies. We offer focus groups consisting of investigators, study coordinators, and when appropriate, study participants, in order to establish enrollment expectations and address potential challenges in an effort to minimize cost to the client.

Our sites have successfully conducted the following infectious disease studies:
  • Common Cold
  •  C. Difficile
  • Fungal Infections
  • Genital / Perianal Warts
  • Hepatitis
  • Herpes genitalis
  • Herpes labialis
  • Herpes zoster
  • HIV
  • Human Papillomavirus (HPV)
  • Influenza
  • Meningitis
  • Onychomycosis
  • Pneumococcus
  • Respriatory Tract Infection
  • Rhinitis
  • Sexually Transmitted Diseases (STDs)
  • Sinusitis
  • Tinea Pedis (Athlete's Foot)
  • Urinary Tract Infection (UTI)
  • Vaccines

Contact us for a complete list of infectious disease enrollment metrics.
Call us: (843) 607-2933  |  email us:  |  follow us:    
Company            Investigator Sites            Therapeutic Expertise            Services            Phase I - IV            Library            News & Events            Contact